111 related articles for article (PubMed ID: 10953048)
41. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
Cheng FH; Chan SW; Rudd JA
Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
[TBL] [Abstract][Full Text] [Related]
42. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
43. Tachykinins as mediators of slow EPSPs in guinea-pig gall-bladder ganglia: involvement of neurokinin-3 receptors.
Mawe GM
J Physiol; 1995 Jun; 485 ( Pt 2)(Pt 2):513-24. PubMed ID: 7545233
[TBL] [Abstract][Full Text] [Related]
44. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
45. Tachykinin NK1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists.
Maggi CA; Patacchini R
Br J Pharmacol; 1992 Aug; 106(4):888-92. PubMed ID: 1327390
[TBL] [Abstract][Full Text] [Related]
46. Tachykinin receptors in rabbit airways--characterization by functional, autoradiographic and binding studies.
Black JL; Diment LM; Alouan LA; Johnson PR; Armour CL; Badgery-Parker T; Burcher E
Br J Pharmacol; 1992 Oct; 107(2):429-36. PubMed ID: 1384914
[TBL] [Abstract][Full Text] [Related]
47. The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum.
Takahashi R; Nishimura J; Hirano K; Naito S; Kanaide H
Br J Pharmacol; 2002 Nov; 137(6):845-54. PubMed ID: 12411416
[TBL] [Abstract][Full Text] [Related]
48. Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors.
Torrens Y; Beaujouan JC; Saffroy M; Glowinski J
Biochem Biophys Res Commun; 2000 Apr; 270(2):668-72. PubMed ID: 10753681
[TBL] [Abstract][Full Text] [Related]
49. Tachykinin receptors in the guinea-pig isolated oesophagus: a complex system.
Kerr KP; Mitchelson F; Coupar IM
Br J Pharmacol; 1997 Mar; 120(6):1021-8. PubMed ID: 9134212
[TBL] [Abstract][Full Text] [Related]
50. Tachykinin receptor expression and function in human esophageal smooth muscle.
Kovac JR; Chrones T; Preiksaitis HG; Sims SM
J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401
[TBL] [Abstract][Full Text] [Related]
51. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
Mussap CJ; Burcher E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
[TBL] [Abstract][Full Text] [Related]
52. Localization and function of NK(3) subtype tachykinin receptors of layer V pyramidal neurons of the guinea-pig medial prefrontal cortex.
Simmons MA; Sobotka-Briner CD; Medd AM
Neuroscience; 2008 Oct; 156(4):987-94. PubMed ID: 18801417
[TBL] [Abstract][Full Text] [Related]
53. Tachykinin-depolarizations mediated by neurokinin-3 receptors in the hamster submandibular ganglion cells.
Yamada T; Endoh T; Suzuki T
Bull Tokyo Dent Coll; 1998 May; 39(2):123-6. PubMed ID: 9667146
[TBL] [Abstract][Full Text] [Related]
54. Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists.
Bissantz C; Bohnert C; Hoffmann T; Marcuz A; Schnider P; Malherbe P
J Med Chem; 2012 Jun; 55(11):5061-76. PubMed ID: 22574973
[TBL] [Abstract][Full Text] [Related]
55. Structure-activity relationship study of tachykinin peptides for the development of novel neurokinin-3 receptor selective agonists.
Misu R; Noguchi T; Ohno H; Oishi S; Fujii N
Bioorg Med Chem; 2013 Apr; 21(8):2413-2417. PubMed ID: 23473945
[TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
57. Neurokinin(3) receptors couple to the activation of neuronal nitric-oxide synthase in stably transfected Chinese hamster ovary cells.
Linden DR; Chell MJ; El-Fakahany EE; Seybold VS
J Pharmacol Exp Ther; 2000 May; 293(2):559-68. PubMed ID: 10773029
[TBL] [Abstract][Full Text] [Related]
58. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
Brunelleschi S; Nicali R; Lavagno L; Viano I; Pozzi E; Gagliardi L; Ghio P; Albera C
Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968
[TBL] [Abstract][Full Text] [Related]
59. Tachykinin NK(3)receptor involvement in anxiety.
Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]